Ad is loading...
AYURF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 30 closing price
GXXY
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Nov 15 closing price
Ad is loading...

AYURF vs GXXY

Header iconAYURF vs GXXY Comparison
Open Charts AYURF vs GXXYBanner chart's image
AYURCANN
Price$0.05
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
GALEXXY
Price$0.02
Change-$0.01 (-33.33%)
Volume$70K
CapitalizationN/A
AYURF vs GXXY Comparison Chart
Loading...
View a ticker or compare two or three
VS
AYURF vs. GXXY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYURF is a Hold and GXXY is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AYURF: $0.05 vs. GXXY: $0.02)
Brand notoriety: AYURF and GXXY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AYURF: 39% vs. GXXY: 276%
Market capitalization -- AYURF: $3.56M vs. GXXY: $0
AYURF [@Pharmaceuticals: Other] is valued at $3.56M. GXXY’s [@Pharmaceuticals: Other] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYURF’s FA Score shows that 0 FA rating(s) are green whileGXXY’s FA Score has 1 green FA rating(s).

  • AYURF’s FA Score: 0 green, 5 red.
  • GXXY’s FA Score: 1 green, 4 red.
According to our system of comparison, both AYURF and GXXY are a bad buy in the long-term.

Price Growth

AYURF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while GXXY (@Pharmaceuticals: Other) price change was -35.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
AYURF YTD gains are higher at: 120.339 vs. GXXY (-56.000).
AYURFGXXYAYURF / GXXY
Capitalization3.56MN/A-
EBITDA-4.24MN/A-
Gain YTD120.339-56.000-215%
P/E Ratio6.50N/A-
Revenue10.2MN/A-
Total Cash1.44MN/A-
Total Debt234KN/A-
FUNDAMENTALS RATINGS
GXXY: Fundamental Ratings
GXXY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRISX14.14-0.02
-0.14%
Harbor International Small Cap Admin
TWQZX15.37-0.09
-0.58%
Transamerica Large Cap Value I2
FIKZX20.90-0.14
-0.67%
Fidelity Advisor Asset Manager 50% Z
GTLOX25.46-0.41
-1.58%
Glenmede Quant US Large Cap Core Eq
RSCCX9.84-0.21
-2.09%
Victory RS Small Cap Equity C

AYURF and

Correlation & Price change

A.I.dvisor tells us that AYURF and PRFX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYURF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYURF
1D Price
Change %
AYURF100%
N/A
PRFX - AYURF
21%
Poorly correlated
+2.08%
HNSPF - AYURF
11%
Poorly correlated
N/A
GXXY - AYURF
7%
Poorly correlated
-35.14%
STEK - AYURF
5%
Poorly correlated
-4.47%
BFRI - AYURF
3%
Poorly correlated
+4.11%
More

GXXY and

Correlation & Price change

A.I.dvisor tells us that GXXY and MILFF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GXXY and MILFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GXXY
1D Price
Change %
GXXY100%
-35.14%
MILFF - GXXY
22%
Poorly correlated
N/A
TEVJF - GXXY
21%
Poorly correlated
-8.21%
MEDIF - GXXY
20%
Poorly correlated
-1.64%
CRDL - GXXY
20%
Poorly correlated
-2.15%
CHBRF - GXXY
15%
Poorly correlated
N/A
More